Radiopharm RAD101 brain imaging data selected for SNO26 presentation

September 14, 2026 8:02 AM

Radiopharm Theranostics (ASX: RAD, Nasdaq: RADX) announced that interim data from its Phase 2b imaging trial of RAD101, a PET ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found